Fiduciary Management Inc. WI Has $211.26 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Management Inc. WI boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 417,624 shares of the healthcare conglomerate's stock after purchasing an additional 36,023 shares during the period. UnitedHealth Group comprises 2.0% of Fiduciary Management Inc. WI's holdings, making the stock its 14th largest position. Fiduciary Management Inc. WI's holdings in UnitedHealth Group were worth $211,259,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. M&T Bank Corp grew its stake in UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after buying an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC lifted its holdings in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Signal Advisors Wealth LLC increased its position in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after buying an additional 1,051 shares during the period. Waycross Partners LLC boosted its position in shares of UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after acquiring an additional 658 shares during the period. Finally, Czech National Bank increased its position in UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock worth $100,937,000 after acquiring an additional 11,426 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on UNH shares. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a report on Tuesday. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Barclays dropped their target price on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research report on Monday. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $608.00.

UnitedHealth Group Trading Up 1.8 %

NYSE:UNH traded up $7.82 on Wednesday, reaching $435.00. 3,876,682 shares of the stock traded hands, compared to its average volume of 4,419,365. The company's 50 day moving average is $508.83 and its 200-day moving average is $537.99. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $417.12 and a 1-year high of $630.73. The firm has a market capitalization of $397.90 billion, a price-to-earnings ratio of 28.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the business posted $6.91 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.